• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS CA 19-9; TEST, CARBOHYDRATE ANTIGEN (CA19-9)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS CA 19-9; TEST, CARBOHYDRATE ANTIGEN (CA19-9) Back to Search Results
Catalog Number 11776193122
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/26/2016
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer stated that they received erroneous results for one patient sample tested for carbohydrate antigen 19-9 (ca 19-9) on an elecsys analyzer.It was asked, but it is not known if any erroneous results were reported outside of the laboratory.The sample initially resulted as 241.5 u/ml.When diluted times 5, the sample resulted as 703.4 u/ml.When diluted times 10, the sample resulted as 1110.0 u/ml.The sample results were said to be non-linear.The patient was not adversely affected.The elecsys analyzer model and serial number were asked for, but not provided.
 
Manufacturer Narrative
The patient has a history of gastric polyp.The patient sample was provided for investigations where it was tested on a cobas 8000 analyzer.The sample resulted as 230.0 u/ml when run on the cobas 8000 analyzer.The sample was manually diluted times 2, resulting with a raw value 180.3 u/ml and resulting with a final value of 361 u/ml when accounting for the dilution factor.The sample was manually diluted times 5, resulting with a raw value 138.3 u/ml and resulting with a final value of 692 u/ml when accounting for the dilution factor.The sample was manually diluted times 10, resulting with a raw value 101.2 u/ml and resulting with a final value of 1012 u/ml when accounting for the dilution factor.When the sample was tested for neuraminidase recovery, it resulted as 230.5 u/ml before ca 19-9 and as 1.22 u/ml after ca 19-9.The sample was diluted times 10 and tested for neuraminidase recovery where it resulted as 103.6 u/ml before ca 19-9 and as 1.38 u/ml after ca 19-9.The cobas 8000 analyzer used in investigations was serial number (b)(4).Ca 19-9 reagent lot number 188632, with an expiration date of may 2017 was used on this analyzer.
 
Manufacturer Narrative
Investigations conclude that non linear dilution behavior of the sample could be verified.The ca 19-9 antigen tends to aggregate and this may lead to non linear dilution behavior in certain samples.This limitation is covered in product labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS CA 19-9
Type of Device
TEST, CARBOHYDRATE ANTIGEN (CA19-9)
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5700438
MDR Text Key46583483
Report Number1823260-2016-00725
Device Sequence Number1
Product Code NIG
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K050231
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 07/06/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number11776193122
Device Lot Number188632
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/26/2016
Initial Date FDA Received06/06/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received06/22/2016
07/06/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age62 YR
-
-